Use of 5α-Reductase Inhibitors for Benign Prostate Hypertrophy and Risk of High-Grade Prostate Cancer: A French Population-Based Study

BJU International - United Kingdom
doi 10.1111/bju.14495
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Wiley

Related search

A Population-Based Nested Case-Control Study in Taiwan: Use of 5 -Reductase Inhibitors Did Not Decrease Prostate Cancer Risk in Patients With Benign Prostate Hyperplasia

Oncologist
Cancer ResearchMedicineOncology
2012English

Current Status of 5α-Reductase Inhibitors in the Treatment of Benign Hyperplasia of Prostate

Indian Journal of Medical Sciences
Medicine
2008English

Metformin Reduces Prostate Cancer Risk Among Men With Benign Prostatic Hyperplasia: A Nationwide Population‐based Cohort Study

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population‐Based Nested Case‐Control Study

Pharmacotherapy
Pharmacology
2019English

High Grade Prostatic Intraepithelial Neoplasia and the Risk of Prostate Cancer

Open Journal of Urology
2018English

Active Treatment in Low-Risk Prostate Cancer: A Population-Based Study

Current Oncology
Oncology
2019English

Prostate Cancer After Subcapsular Prostatectomy Diagnosed as Benign Prostate Hypertrophy-Clinico-Pahhological Analysis

Japanese Journal of Urology
Urology
1992English

Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- And High-Grade Prostate Cancer

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
2015English

Smoking and Risk of Low- And High-Grade Prostate Cancer: Results From the REDUCE Study

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy